Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aliskiren vs HCTZ in Essential Hypertension
NCT00294710Phase 3Completed
- Sponsor
- Novartis
- Start
- Mar 2005
- Primary completion
- Jul 2006
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of aliskiren in essential hypertension, sponsored by Novartis. Started Mar 2005; status: completed.
02
Drugs
aliskiren
03
Conditions
essential hypertension
Beyond the preview
Go deeper on NCT00294710.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00294710.